Project Grant R21AI196827
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a $427,625 Project Grant on February 2, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct fundamental research on viral infection sensing mechanisms in Caenorhabditis elegans. The research will investigate how the model organism recognizes and responds to RNA virus infection, specifically focusing on Orsay virus (ORV), the...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $899,850 to the Whitehead Institute for Biomedical Research on February 20, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports a five-year project (through January 31, 2031) investigating how apicomplexan parasites, such as Toxoplasma and Plasmodium, recognize and invade host cells. The research deliverables include peer-reviewed publications and...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant of $155,454 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period August 1, 2025, through July 31, 2027. This award funds research to identify and characterize molecular mechanisms of Venezuelan Equine Encephalitis Virus (VEEV) entry into host cells and to develop enhanced therapeutic interventions targeting...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $416,005 Project Grant to the University of California Santa Cruz under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 15, 2025, with a completion date of July 31, 2027. This award funds research to establish the structural and molecular basis for human astrovirus (HAstV) entry into human cells, with the ultimate objective of identifying functional sites on...
- Federal Grant Award Summary Funding Agency and Program: The National Institute of Allergy and Infectious Diseases (NIAID) awarded this Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855). Award Details and Scope: Oregon State University received $495,688 in obligated federal funds on February 2, 2026, for a five-year project concluding January 31, 2031. The award supports mechanistic and structural studies on the biosynthesis of ureido-containing natural...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Princeton University $133,600 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 24, 2025, with completion targeted for March 31, 2027. This Project Grant funds investigative research into Virus Induced Chaperone Enriched (VICE) domain functions during Herpes Simplex Virus Type-1 (HSV-1) infection. The research employs advanced mass spectrometry and...
- Federal Project Grant Award Summary Tufts University School of Medicine received a $243,600 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 23, 2026, with a completion date of January 31, 2028. The award funds research investigating the role of CLCC1, an endoplasmic reticulum protein, in herpesvirus nuclear egress—the process by which viral capsids exit the cell...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Boston University Medical Campus a $100,228 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 27, 2026, with a completion date of May 31, 2029. This award supports research into the regulation of Vesicular Stomatitis Virus (VSV) messenger RNA translation mechanisms. The project aims to characterize how VSV, a member of the Mononegavirales order...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Research Institute at Nationwide Children's Hospital a $708,193 Project Grant effective May 19, 2026, through April 30, 2031, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports fundamental research to elucidate the entry mechanism of hepatitis E virus (HEV), specifically examining how quasi-enveloped virions (EHEV) penetrate host cells. The...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Texas Medical Branch at Galveston a $2.92 million Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective September 1, 2025, through August 31, 2029. This award supports fundamental research investigating norovirus capsid dynamics and adaptive immune evasion mechanisms. The research utilizes a mouse norovirus model system to elucidate...
Funding Agency and Program: The National Institute of Allergy and Infectious Diseases (NIAID) awarded this Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) in the amount of $234,750.00, with an award date of July 16, 2026, and a completion date of June 30, 2028. Research Deliverables: This grant supports fundamental research investigating the role of FSHR-1, a G protein-coupled receptor (GPCR), as a key host receptor mediating Orsay virus (ORV) entry into Caenorhabditis elegans intestinal cells. The project will advance understanding of viral pathogenesis mechanisms through in vivo studies of host-pathogen interactions, leveraging the genetic tractability and optical transparency of C. elegans—the only known natural host organism for ORV. Primary research deliverables include characterization of the structural interaction between the viral CP-D pentameric head fiber knob domain and FSHR-1, elucidation of receptor internalization and clathrin-mediated endocytosis mechanisms triggered by viral binding, and validation of FSHR-1's role as an essential entry receptor. Research will be conducted at William Marsh Rice University's Office of Sponsored Projects in Houston, Texas, and is expected to generate peer-reviewed publications, structural data, and mechanistic insights applicable to understanding viral infection dynamics in model organisms and potentially informing broader infectious disease research.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $234.8k | 7/16/26 |